The City of Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Editor's note: An earlier version of this story incorrectly stated that a specific type of insulin was excluded from CVS 2017 ...
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday. The move is aimed at addressing ...
Medicare Part D spending on diabetes drugs increased 364% from 2019 to 2023, driven by GLP-1 and SGLT-2 inhibitors. Metformin spending decreased by 5%, contrasting with the surge in other diabetes ...
WASHINGTON -- Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results